Calvin Q. Pan

Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both.

Dan-Qin Sun, Wen-Yue Liu, A. Lonardo, 2024, Journal of hepatology.

Letter: Boosting non-invasive tests-Opportunities and challenges from resmetirom.

M. Zheng, Gong Feng, Calvin Q. Pan, 2024, Alimentary pharmacology & therapeutics.

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

John F. Flaherty, M. Buti, C. Yurdaydın, 2023, Alimentary pharmacology & therapeutics.